Lataa...

Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design

The approval of EGFR and ALK directed tyrosine kinase inhibitors materialized the concept of tailoring therapy on the basis of specific biomarkers for treating patients with NSCLC. Research for other biologics, although demonstrating clinical benefit, has been less successful so far for producing bi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Pers Med
Päätekijät: Dimou, Anastasios, Papadimitrakopoulou, Vassiliki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4263964/
https://ncbi.nlm.nih.gov/pubmed/25563357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm4030386
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!